Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide

Zhou,Yunchuan; Zhou,Yang; Yu,Shanshan; Wu,Jingxian; Chen,Yanlin; Zhao,Yong

doi:10.3892/ijmm.2015.2205

Sulfiredoxin-1 exerts anti-apoptotic and neuroprotective effects against oxidative stress-induced injury in rat cortical astrocytes following exposure to oxygen-glucose deprivation and hydrogen peroxide

Authors:
- Yunchuan Zhou
- Yang Zhou
- Shanshan Yu
- Jingxian Wu
- Yanlin Chen
- Yong Zhao
View Affiliations

Affiliations: Department of Pathology, Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: May 8, 2015 https://doi.org/10.3892/ijmm.2015.2205
Pages: 43-52
Copyright: © Zhou et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sulfiredoxin 1 (Srxn1), an endogenous antioxidant protein, plays an important neuroprotective role in cerebral ischemia. However, the exact mechanisms of action of Srxn1 in cerebral ischemia have not yet been fully elucidated. Therefore, in the present study, rat primary cortical astrocytes transfected with a lentiviral vector encoding short hairpin RNA (shRNA) were exposed to oxygen-glucose deprivation (OGD) for 4 h or to 100 µM hydrogen peroxide (H2O2) for 6 h, in order to construct an in vitro model of cerebral ischemia-induced damage. We found that following exposure to OGD or H2O2, the knockdown of Srxn1 resulted in a decrease in cell viability, as shown by MTS assay, an increase in cell damage, as shown by lactate dehydrogenase assay and an increase in cellular apoptosis, as shown by Hoechst 33342 staining and flow cytometry. Furthermore, we found that following exposure to OGD or H2O2, the knockdown of Srxn1 resulted in a decrease in mitochondrial transmembrane potential (Δψm) as indicated by JC-1 staining, an increase in the cytoplasmic expression of cytochrome c (Cyt.C), caspase-3, caspase-9, poly(ADP-ribose) polymerase (PARP) and Bax protein at the protein level, but a decrease in the expression of the anti-apoptotic Bcl-2 protein; these effects were tightly associated with the mitochondrial apoptotic pathway. However, we found that there was no obvious change in the intracellular calcium ([Ca2+]i) levels and caspase-12 expression following the knockdown of Srxn1. Taken together, the results from the present study demonstrate that Srxn1 protects primary rat cortical astrocytes from OGD- or H2O2-induced apoptosis and that involves the activation of the mitochondrial apoptotic pathway, which suggests that Srxn1 may be a potential target in the treatment of cerebral ischemia.

View Figures

View References

1	Li Q, Yu S, Wu J, Zou Y and Zhao Y: Sulfiredoxin-1 protects PC12 cells against oxidative stress induced by hydrogen peroxide. J Neurosci Res. 91:861–870. 2013. View Article : Google Scholar : PubMed/NCBI
2	Kinsner A, Pilotto V, Deininger S, et al: Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation. J Neurochem. 95:1132–1143. 2005. View Article : Google Scholar : PubMed/NCBI
3	Papadia S, Soriano FX, Leveille F, et al: Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 11:476–487. 2008. View Article : Google Scholar : PubMed/NCBI
4	Biteau B, Labarre J and Toledano MB: ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature. 425:980–984. 2003. View Article : Google Scholar : PubMed/NCBI
5	Rhee SG, Jeong W, Chang TS and Woo HA: Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance. Kidney Int Suppl. 72:S3–S8. 2007. View Article : Google Scholar
6	Vivancos AP, Castillo EA, Biteau B, et al: A cysteine-sulfinic acid in peroxiredoxin regulates H₂O₂-sensing by the antioxidant Pap1 pathway. Proc Natl Acad Sci USA. 102:8875–8880. 2005. View Article : Google Scholar
7	Findlay VJ, Tapiero H and Townsend DM: Sulfiredoxin: a potential therapeutic agent? Biomed Pharmacother. 59:374–379. 2005. View Article : Google Scholar : PubMed/NCBI
8	Soriano FX, Leveille F, Papadia S, et al: Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J Neurochem. 107:533–543. 2008. View Article : Google Scholar : PubMed/NCBI
9	Kang KW, Lee SJ and Kim SG: Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal. 7:1664–1673. 2005. View Article : Google Scholar : PubMed/NCBI
10	Singh A, Ling G, Suhasini AN, et al: Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med. 46:376–386. 2009. View Article : Google Scholar
11	Bell KF, Al-Mubarak B, Fowler JH, et al: Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc Natl Acad Sci USA. 108:E1–E2. 2011. View Article : Google Scholar :
12	Noh YH, Baek JY, Jeong W, Rhee SG and Chang TS: Sulfiredoxin translocation into mitochondria plays a crucial role in reducing hyperoxidized peroxiredoxin III. J Biol Chem. 284:8470–8477. 2009. View Article : Google Scholar : PubMed/NCBI
13	Baek JY, Han SH, Sung SH, et al: Sulfiredoxin protein is critical for redox balance and survival of cells exposed to low steady-state levels of H₂O₂. J Biol Chem. 287:81–89. 2012. View Article : Google Scholar :
14	Wu J, Li Q, Wang X, et al: Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One. 8:e598432013. View Article : Google Scholar : PubMed/NCBI
15	Wu X, Zhao J, Yu S, Chen Y, Wu J and Zhao Y: Sulforaphane protects primary cultures of cortical neurons against injury induced by oxygen-glucose deprivation/reoxygenation via anti-apoptosis. Neurosci Bull. 28:509–516. 2012. View Article : Google Scholar : PubMed/NCBI
16	Liu SB, Zhang N, Guo YY, et al: G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors. J Neurosci. 32:4887–4900. 2012. View Article : Google Scholar : PubMed/NCBI
17	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
18	Song S, Zhou J, He S, et al: Expression levels of microRNA-375 in pancreatic cancer. Biomed Rep. 1:393–398. 2013.
19	Lin CJ, Chen TH, Yang LY and Shih CM: Resveratrol protects astrocytes against traumatic brain injury through inhibiting apoptotic and autophagic cell death. Cell Death Dis. 5:e11472014. View Article : Google Scholar : PubMed/NCBI
20	Han F, Tao RR, Zhang GS, et al: Melatonin ameliorates ischemic-like injury-evoked nitrosative stress: Involvement of HtrA2/PED pathways in endothelial cells. J Pineal Res. 50:281–291. 2011. View Article : Google Scholar : PubMed/NCBI
21	Sung DK, Chang YS, Kang S, Song HY, Park WS and Lee BH: Comparative evaluation of hypoxic-ischemic brain injury by flow cytometric analysis of mitochondrial membrane potential with JC-1 in neonatal rats. J Neurosci Methods. 193:232–238. 2010. View Article : Google Scholar : PubMed/NCBI
22	Zhao J, Kobori N, Aronowski J and Dash PK: Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett. 393:108–112. 2006. View Article : Google Scholar
23	Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab. 21:2–14. 2001. View Article : Google Scholar : PubMed/NCBI
24	Hossain MA: Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int J Dev Neurosci. 26:93–101. 2008. View Article : Google Scholar
25	Kawamura M, Nakajima W, Ishida A, Ohmura A, Miura S and Takada G: Calpain inhibitor MDL 28170 protects hypoxic-ischemic brain injury in neonatal rats by inhibition of both apoptosis and necrosis. Brain Res. 1037:59–69. 2005. View Article : Google Scholar : PubMed/NCBI
26	Northington FJ, Graham EM and Martin LJ: Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res Brain Res Rev. 50:244–257. 2005. View Article : Google Scholar : PubMed/NCBI
27	Stellwagen D and Malenka RC: Synaptic scaling mediated by glial TNF-alpha. Nature. 440:1054–1059. 2006. View Article : Google Scholar : PubMed/NCBI
28	Perea G, Yang A, Boyden ES and Sur M: Optogenetic astrocyte activation modulates response selectivity of visual cortex neurons in vivo. Nat Commun. 5:32622014. View Article : Google Scholar : PubMed/NCBI
29	Lopez-Hidalgo M and Schummers J: Cortical maps: a role for astrocytes? Curr Opin Neurobiol. 24:176–189. 2014. View Article : Google Scholar : PubMed/NCBI
30	Giffard RG and Swanson RA: Ischemia-induced programmed cell death in astrocytes. Glia. 50:299–306. 2005. View Article : Google Scholar : PubMed/NCBI
31	Yu AC, Wong HK, Yung HW and Lau LT: Ischemia-induced apoptosis in primary cultures of astrocytes. Glia. 35:121–130. 2001. View Article : Google Scholar : PubMed/NCBI
32	Wang J, Deng X, Zhang F, Chen D and Ding W: ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes. Nanoscale Res Lett. 9:1172014. View Article : Google Scholar : PubMed/NCBI
33	Xie Z, Smith CJ and Van Eldik LJ: Activated glia induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia. 45:170–179. 2004. View Article : Google Scholar : PubMed/NCBI
34	Takuma K, Baba A and Matsuda T: Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol. 72:111–127. 2004. View Article : Google Scholar : PubMed/NCBI
35	Desagher S and Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10:369–377. 2000. View Article : Google Scholar : PubMed/NCBI
36	Wang X: The expanding role of mitochondria in apoptosis. Genes Dev. 15:2922–2933. 2001.PubMed/NCBI
37	Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem. 274:5053–5060. 1999. View Article : Google Scholar : PubMed/NCBI
38	Ferri KF and Kroemer G: Organelle-specific initiation of cell death pathways. Nat Cell Biol. 3:E255–E263. 2001. View Article : Google Scholar : PubMed/NCBI
39	Nakagawa T, Zhu H, Morishima N, et al: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:98–103. 2000. View Article : Google Scholar : PubMed/NCBI
40	Leist M and Nicotera P: Apoptosis, excitotoxicity, and neuropathology. Exp Cell Res. 239:183–201. 1998. View Article : Google Scholar : PubMed/NCBI
41	Iijima T, Mishima T, Akagawa K and Iwao Y: Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res. 993:140–145. 2003. View Article : Google Scholar : PubMed/NCBI
42	Ye R, Li N, Han J, et al: Neuroprotective effects of ginsenoside Rd against oxygen-glucose deprivation in cultured hippocampal neurons. Neurosci Res. 64:306–310. 2009. View Article : Google Scholar : PubMed/NCBI
43	Acehan D, Jiang X, Morgan DG, Heuser JE, Wang X and Akey CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell. 9:423–432. 2002. View Article : Google Scholar : PubMed/NCBI
44	Ji YB, Qu ZY and Zou X: Juglone-induced apoptosis in human gastric cancer SGC-7901 cells via the mitochondrial pathway. Exp Toxicol Pathol. 63:69–78. 2011. View Article : Google Scholar
45	Khan M, Ding C, Rasul A, et al: Isoalantolactone induces reactive oxygen species mediated apoptosis in pancreatic carcinoma PANC-1 cells. Int J Biol Sci. 8:533–547. 2012. View Article : Google Scholar : PubMed/NCBI
46	Wong WW and Puthalakath H: Bcl-2 family proteins: the sentinels of the mitochondrial apoptosis pathway. IUBMB Life. 60:390–397. 2008. View Article : Google Scholar : PubMed/NCBI
47	Moldoveanu T, Follis AV, Kriwacki RW and Green DR: Many players in BCL-2 family affairs. Trends Biochem Sci. 39:101–111. 2014. View Article : Google Scholar : PubMed/NCBI
48	Martinou JC and Youle RJ: Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
49	Shacka JJ and Roth KA: Regulation of neuronal cell death and neurodegeneration by members of the Bcl-2 family: therapeutic implications. Curr Drug Targets CNS Neurol Disord. 4:25–39. 2005. View Article : Google Scholar : PubMed/NCBI
50	Szegezdi E, Fitzgerald U and Samali A: Caspase-12 and ER-stress-mediated apoptosis: the story so far. Ann NY Acad Sci. 1010:186–194. 2003. View Article : Google Scholar
51	Sergeev IN: Calcium signaling in cancer and vitamin D. J Steroid Biochem Mol Biol. 97:145–151. 2005. View Article : Google Scholar : PubMed/NCBI